Kilroy Conor 4

What Happened

• Conor Kilroy, Chief Legal Officer and Secretary of Aura Biosciences (AURA), sold 11,738 shares on April 16, 2026. The weighted-average price reported was $7.02, producing proceeds of approximately $82,401. The sale was reported as a disposal (S) and, per the filing, was an automatic sale to cover tax withholding obligations tied to the vesting of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-04-16.
• Shares sold: 11,738; weighted-average price: $7.02; total proceeds ≈ $82,401.
• Reported price range: $7.02 to $7.05 (sales occurred in multiple trades; weighted average shown).
• Reason: Automatic sale to satisfy tax withholding on vested RSUs (footnote F1 — not at the reporting person’s discretion).
• Ownership after transaction: Not disclosed in the excerpt provided in this summary (see the full Form 4 for total holdings).
• Timeliness: Filing date matches the report date (filed 2026-04-16), indicating a timely report.
• Reporting person’s offer: The filer will provide a breakdown of the number of shares sold at each price in the stated range upon request (footnote F2).

Context

• This was a tax-withholding sale related to RSU vesting (routine, automatic), not an open-market discretionary sell motivated by trading decisions. Such transactions are common when companies or insiders sell shares to cover payroll or tax obligations and do not necessarily signal a change in the insider’s view of the company.